Alexander Biederstadt
Ismaninger Str. 22
Munich, BY 81675, Germany
Munich, BY 81675, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: February 28, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency.
Journal: Cancer cell
Published: December 02, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.
Journal: Science translational medicine
Published: September 11, 2024
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.
Journal: Nature
Published: May 16, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.
Journal: Cancer discovery
Published: January 18, 2024
Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center retrospective analysis.
Journal: Transfusion
Published: November 08, 2023
Multiplexed engineering and precision gene editing in cellular immunotherapy.
Journal: Frontiers in immunology
Published: October 06, 2022
Natural killer cells in antitumour adoptive cell immunotherapy.
Journal: Nature reviews. Cancer
Published: June 13, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.
Journal: Nature medicine
Published: December 15, 2021
Last Updated: 09/26/2026